期刊文献+

内蒙古地区汉族多囊卵巢综合征患者临床特征研究 被引量:1

Analysis of Clinical Data in Inner Mongolia Chinese Women with Polycystic Ovary Syndrome
原文传递
导出
摘要 目的:分析总结多囊卵巢综合征(Polycystic ovary syndrome,PCOS)合并不育患者的临床及内分泌代谢特征,为PCOS的临床诊治提供依据。方法:回顾性分析120例PCOS患者(其中肥胖型73例,非肥胖型47例)的临床特征及内分泌、空腹血糖(FPG)、空腹胰岛素(FINS)等检查指标。用稳态模型胰岛素抵抗指数(HOMA-IR)、稳态模型胰岛素分泌指数(HOMA-IS)、空腹胰岛素敏感指数(ISI)评估胰岛素敏感性。结果:两组患者睾酮(T)、黄体生成素(LH)、卵泡刺激素(FSH)、LH/FSH无显著差别。肥胖组的FPG和FINS水平明显高于非肥胖组。两组胰岛素抵抗(IR)发生率分别为86.30%和51.06%。肥胖组的IR、ISI均明显高于非肥胖组。结论:PCOS患者肥胖发生率较高,肥胖型PCOS患者较非肥胖型患者存在更严重的代谢紊乱。减重、改善IR不仅可以改善PCOS不育情况,更是预防2型糖尿病、心血管疾病等远期并发症的关键。 Objective:To provide basis for the clinical diagnose and treatment of polycystic ovary syndrome(PCOS).Methods: One hundred and twenty PCOS patients were included in this retrospective study.They were divided into obese group(n=73)and non-obese group(n=47)according to body mass index(BMI)and waist hip ratio(WHR).Clinical presentations,serum hormonal levels, glucose levels and insulin levels were reviewed.Result:FSH did not differ significantly between the two groups,nor did LH or LH/FSH, T,or HOMA-IS with the exception of significantly higher FBG,FINS,HOMA-IR(marker for insulin resistance)and ISI in the obese PCOS group(P0.05).Conclusion:The prevalence of obesity is higher in PCOS than cornmon person.The state of obesity has a positive relation with insulin resistance(IR).Obese women with PCOS have a high prevalence of IR,compared with non-obese controls. Losing weight is the primary therapy for PCOS.
出处 《现代生物医学进展》 CAS 2009年第23期4507-4509,共3页 Progress in Modern Biomedicine
基金 内蒙古教育厅项目(NJZY08102)
关键词 多囊卵巢综合征 肥胖 胰岛素抵抗 Polycystic ovary syndrome Obesity Insulin resistance
  • 相关文献

参考文献8

  • 1Cussons AJ, Watts GF, Burke V, et al. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome [J]. Hum Reprod, 2008,23 (10): 2352-2358.
  • 2The Rotterdam ESHRE/ASRM-sponsored PCOS ConsensusWork-shop Group.Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS) [J]. Hum Reprod, 2004, |9(1): 41-47.
  • 3Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome[J]. J Hum Reprod Sci, 2009,2(1): 12-17.
  • 4Martinez-Bermejo E, Luque-Ramirez M, Escobar-Morreale HF. Obesity and the polycystic ovary syndrome [J]. Minerva Endocrinol, 2007,32(3): 129-140.
  • 5Yeede HI, Hutchison S, Zoungas S, et al. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS[J]. Endocrine, 2006,30(1):45-53.
  • 6Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome [J]. BJOG, 2006,113(10):1148-1159.
  • 7Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J].Hum Reprod, 2008,23(3):462-477.
  • 8Magnotti M, Futterweit W. Obesity and the polycystic ovary syndrome[J]. Med Clin North Am, 2007,91(6):1151-1168.

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部